Eating Disorders Trial, Recruiting NCT05197309 Sponsor: Icahn School of Medicine at Mount Sinai Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT05197309
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be female
  • You must be between 18 and 40 years old
  • Your body mass index (BMI, a measure of height and weight) must be 18.5 or above
  • You must speak English
  • You must be in generally stable health, confirmed by a doctor through basic health checks and blood tests
  • If joining the weight-restored anorexia group: you must have been formally diagnosed with Anorexia Nervosa according to medical guidelines (DSM-5)
  • If joining the weight-restored anorexia group: your weight must have recovered to a healthy BMI (18.5 or above) within the past 6 months after previously being underweight

Who may not be able to join:

  • People who have ever been diagnosed with a psychotic disorder or bipolar disorder
  • People who currently have a problem with substance use (such as alcohol or drugs)
  • People who are currently taking any medications that could affect how the body processes energy or sugar (you would need to stop such medications at least 2 weeks before the main study visit — confirm with trial site)
  • People who have attempted suicide in the past 6 months or who are currently considered at high risk of suicide
  • People who have a serious current medical condition or a condition affecting the body's metabolism, including diabetes or pregnancy
  • If joining the healthy comparison group: people who have ever been diagnosed with any eating disorder
  • If joining the healthy comparison group: people who currently have an active depressive disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chinara Tate, Icahn School of Medicine at Mount Sinai

Phone: (212) 659-8724

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 November 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of adverse events; Percent completion of food; Percent completion of ketone logs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov